Skip to main content
Log in

Epidemiological Context of Signalling

  • Conference Paper
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Epidemiology has become the conscience and soul of signal detection and interpretation from assuring insights into the strengths and limitations of the data source to articulating the disease natural history and its relationship to other diseases, outcomes and treatments. The epidemiologist has struggled to bring several issues into focus including the analysis and interpretation of surveillance data, the integration of signalling and causality criteria, the statistical issues of multiple comparisons and multiple looks at the data, whether one significant disproportion is a signal or whether it should persist over time before it is ‘declared’. However, epidemiology, like signalling, has its proper place with its own strengths and limitations. This paper will attempt to bring everyone up to speed on the role of epidemiology in the context of signalling and how signalling fits into the broader context of epidemiology, how perceptions and biases may affect our application of these methods and why context and communication have become so important in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Erkinjuntti T, Ostbye T, Steenhuis R, et al. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997; 337(23): 1667–74

    Article  PubMed  CAS  Google Scholar 

  2. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 2002; 287(3): 337–44

    Article  PubMed  Google Scholar 

  3. Reidenberg MM, Lowenthal DT. Adverse nondrug reactions. N Engl J Med 1968; 279(13): 678–9

    Article  PubMed  CAS  Google Scholar 

  4. Meyer FP, Troger U, Rohl FW. Adverse nondrug reactions: an update. Clin Pharmacol Ther 1996; 60(3): 347–52

    Article  PubMed  CAS  Google Scholar 

  5. Last JM. A dictionary of epidemiology. 3rd ed. Oxford: Oxford University Press, 1995

    Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this paper. The author has no conflicts of interest that are directly relevant to the content of this paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul Stang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stang, P. Epidemiological Context of Signalling. Drug-Safety 30, 611–613 (2007). https://doi.org/10.2165/00002018-200730070-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200730070-00007

Keywords

Navigation